eGenomics

eGenomics was a biotechnology company specializing in microbial genomics and bioinformatics, primarily focused on the rapid identification and tracking of infectious diseases. The company developed a proprietary platform for automated DNA sequence analysis that enabled high-resolution strain typing for pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA), Mycobacterium tuberculosis, and Vancomycin-resistant Enterococci (VRE). This technology allowed healthcare providers to monitor and control hospital-acquired infections through precise molecular epidemiology and real-time data analysis. Founded in 1999 and based in New York, eGenomics was a pioneer in applying genomic sequencing to public health and clinical settings. In 2005, the company was acquired by Eurofins Scientific, where its technologies were integrated into Eurofins' global genomics and clinical diagnostics portfolio.